MoneyWorks4Me

Windlas Biotech informs about conference call transcript

14 Feb 2023 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Windlas Biotech has informed that it attached Q3 FY23 Earnings Conference Call Transcript.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..